stockrowPulmonx Corporation (LUNG) vs Nyxoah SA (NYXH)
- Pulmonx Corporation LUNG 2.60 +1.56%
- Nyxoah SA NYXH 0.81 0.00%
Pulmonx Corporation and Nyxoah SA are both Medical Devices companies. Pulmonx Corporation is the larger, with a market value of $111.5M against $82.6M — 1.3× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −3.15%. Pulmonx Corporation has the higher net margin (−47.9% vs −446.4%) and the lower return on invested capital (−129.9% vs −117.8%). Across the 18 metrics below, Pulmonx Corporation leads on 11 and Nyxoah SA on 7.
Valuation
Profitability
| Metric | LUNG | NYXH | Medical Devices median |
|---|---|---|---|
| Gross margin | 77.42% | 60.16% | 57.76% |
| Operating margin | (44.39%) | (391.25%) | (15.07%) |
| Net margin | (47.93%) | (446.39%) | (14.45%) |
| Free cash flow margin | (28.85%) | (344.99%) | (3.88%) |
| Return on equity | (90.31%) | (124.41%) | (10.35%) |
| Return on assets | (34.25%) | (68.23%) | (17.26%) |
| Return on invested capital | (129.86%) | (117.82%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack